GLENMARK.NS
GLENMARK.NS
INE935A01035
GLENMARK PHARMACEUTICALS
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
647.14B EUR
622.16B EUR
601.57B EUR
574.26B EUR
Enterprise Value
641.36B EUR
622.16B EUR
595.76B EUR
574.26B EUR
Valuation Multiples
Trailing P/E
36x
34.6x
44.17x
54.15x
Forward P/E
23.62x
--
--
--
Price to Sales
3.65x
3.54x
3.6x
4.43x
Price to Book
6.16x
--
5.72x
--
EV/Revenue
3.62x
3.54x
3.56x
4.43x
EV/EBITDA
13.27x
11.75x
11.84x
14.07x
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
--
--
--
--
ende